Ruthenium, Nitric Oxide and Disease
- 1 October 1995
- journal article
- Published by Johnson Matthey in Platinum Metals Review
- Vol. 39 (4) , 150-159
- https://doi.org/10.1595/003214095x394150159
Abstract
Recent discoveries in the biological sciences have revealed that nitric oxide has a number of important physiological functions and is also implicated in a number of diseases. This realisation has provided a stimulus for nitric oxide related drug research and development. In this review new work aimed at the development of potential therapeutic use of ruthenium compounds, particularly ruthenium(III) polyaminocarboxylate, JM1226, is presented and discussed in the context of the chemistry and biology of nitric oxide. Based on these studies, prospects for the further development of JM1226 appear promising.This publication has 18 references indexed in Scilit:
- NITRIC OXIDE SYNTHASES: WHY SO COMPLEX?Annual Review of Nutrition, 1994
- How does NO activate hemeproteins?FEBS Letters, 1994
- Metal Compounds in Therapy and DiagnosisScience, 1993
- Reactions of the bioregulatory agent nitric oxide in oxygenated aqueous media: Determination of the kinetics for oxidation and nitrosation by intermediates generated in the nitric oxide/oxygen reactionChemical Research in Toxicology, 1993
- Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shockThe Lancet, 1991
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Preparation and structure of ethylenediaminetetraacetate complexes of ruthenium(II) with dinitrogen, carbon monoxide, and other .pi.-acceptor ligandsInorganic Chemistry, 1981
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- Properties and reactivities of pentadentate ethylenediaminetetraacetate complexes of ruthenium(III) and -(II)Inorganic Chemistry, 1979
- Reactions of nitric oxide coordinated to transition metalsChemical Reviews, 1979